Pasithea Therapeutics Corp (KTTA) Financials

$0.51

$-0.02 (-3.77%)

As on 14-Sep-2026 16:00EDT

Market cap

$18 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	0.49	0.49	0.02
Cost of Revenue	0.65	0.66	0.65	0.65	0.01	0.02
Gross Profit	-0.65	-0.66	-0.65	-0.65	-0.01	0.00
Operating Expenses	23.48	20.86	14.25	15.98	12.58	4.51
Operating Profit (EBIT)	-23.96	-20.86	-14.25	-15.98	-12.59	-4.51
Other Income	--	--	--	--	--	--
Profit before Tax	-21.29	-20.43	-13.90	-15.51	-11.73	-2.17
Provision for Tax	--	--	--	453.91	-0.88	0.00
Profit after Tax (Net Income)	-21.29	-20.43	-13.90	-15.96	-13.94	-2.17
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-2.17

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	49.84	55.22	14.78	23.40	42.50	51.42
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.03	0.05	0.16	0.08	0.80	1.45
Current Liabilities	1.84	4.97	1.12	2.63	1.88	0.45
Total Liabilities	53.55	60.24	16.06	26.12	45.18	53.32

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.47	3.78	8.70	9.42	11.10	0.02
Current Assets	48.24	56.46	7.37	16.69	34.08	53.30
Total Assets	53.55	60.24	16.06	26.12	45.18	53.32
Total Debt*	--	--	--	0.08	0.50	--
Net Current Assets	46.41	51.49	6.25	14.06	32.20	52.85

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-15.21	-13.92	-13.43	-13.69	-3.17
Cash Flow from Investing Activities	--	0.01	--	0.40	-2.93	-0.02
Cash from Financing Activities	--	63.52	4.52	-3.73	-3.21	55.93
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-3.00	-2.91	-12.69	-15.32	-10.70	-1.89
Cash EPS ($)	-1.31	-2.81	-12.09	-14.83	-10.68	-1.89
Adjusted Book Value ($)	1.49	7.85	13.49	22.46	32.64	44.70
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.16	-12.70	-12.89	-10.51	-2.76
Free Cash Flow per Share ($)	--	-2.16	-12.70	-12.92	-10.60	-2.78

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-58.36	-72.68	-48.02	-29.52	-8.41
ROE (%)	-40.53	-58.36	-72.83	-48.44	-29.68	-8.41
ROA (%)	-58.90	-53.54	-65.93	-44.78	-28.30	-8.11
EBIT Margin (%)	--	--	--	-3,284.16	-2,410.37	-14,427.12
Net Margin (%)	--	--	--	-3,280.52	-2,864.29	-14,430.49
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	-1.00	--	31.30	--
EBIT Growth (%)	-75.21	-46.37	10.82	-36.25	-439.71	-2,020.92
Net Profit Growth (%)	-58.22	-46.91	12.89	-14.53	-541.19	-3,435.56
EPS Growth (%)	68.97	0.77	0.17	-0.43	-4.66	-10.58
Book Value Growth (%)	163.46	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.44	-0.25	-0.48	-0.06	-0.94
Price / Book Value	0.37	0.16	0.23	0.33	0.02	0.04
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.90	2.28	508.74	0.56	2.71	23.45
Close Price ($)	0.52	1.29	3.15	148.00	12.83	35.40
High Price ($)	2.06	3.85	9.25	168.00	39.20	170.00
Low Price ($)	0.28	0.28	2.37	5.25	10.80	27.80
Market Cap ($ Cr)	17.71	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	0.00	0.01	--
Short term debt to equity ratio	--	--	--	0.00	0.00	--
Current Ratio	26.25	11.35	6.58	6.34	18.15	119.17
Quick Ratio	26.25	--	--	6.35	18.15	--
Interest Coverage	--	--	--	--	-114,979.26	-4,277.58

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	8.32	62.10	--
Asset Turnover	--	--	--	0.01	0.01	0.00
Receivable days	--	--	--	128.60	226.80	--
Inventory Days	--	--	-22.79	-11.41	0.07	--
Payable days	--	617.33	1,033.30	1,136.03	69,144.86	4,798.29
Cash Conversion Cycle	--	--	--	-1,018.83	-68,917.98	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.